Article thumbnail

Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin

By Antonio Pérez, Pedro Mezquita Raya, Antonio Ramírez de Arellano, Teresa Briones, Barnaby Hunt and William J. Valentine
Publisher: 'Springer Science and Business Media LLC'
Year: 2015
DOI identifier: 10.1007/s13300-015-0103-5
OAI identifier:
Provided by: MUCC (Crossref)

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.